PKvitality

About the deal

Paris, January 7th, 2020 – PKvitality, a French company specialized in bio wearables, has signed an agreement with Beurer GmBH, the German medical product and well-being company. PKvitality is currently working on the development of K’Watch project, a Continuous Glucose Monitor (CGM) in a form of a smartwatch.

The agreement provides PKvitality with €2,25m funding to further develop the K’Watch and reach First in Man. Beurer GmBH has acquired exclusive commercialisation rights for Germany, Austria and Italian tenders, agreeing to a sales volume that will contribute significantly to PKvitality’s overall commercial volume.

Beurer GmbH, created in 1919, employs more than 900 staff and manufactures and commercialises more than 500 products in Europe, US and Asia, and is one of the major distributors of Blood Glucose Meters in Germany and Austria. Beurer believes that PKvitality’s K’Watch, will become a leading product to measure blood glucose level in real time. The patient-friendly and cost-effective concept of the K’Watch is being developed by high skilled professionals and industry experts.